Vertigo, a common clinical symptom, often presents diagnostic and therapeutic challenges to healthcare professionals. This article aims to provide a comprehensive clinical approach to unraveling vertigo.
Vertigo is primarily a symptom of vestibular dysfunction. It can be peripheral, originating from the inner ear, or central, sourced from the brainstem or cerebellum. Conditions such as Benign Paroxysmal Positional Vertigo (BPPV), Meniere's disease, and vestibular neuritis are common peripheral causes. Central causes include migraines, multiple sclerosis, and cerebrovascular diseases.
An accurate history is crucial in diagnosing vertigo. The onset, duration, frequency, and associated symptoms can provide valuable clues. Physical examination should include a thorough neurological and otologic assessment. Special tests like the Dix-Hallpike maneuver or the HINTS (Head-Impulse, Nystagmus, Test of Skew) can be performed to differentiate between peripheral and central causes.
Management of vertigo is multifaceted and depends on the underlying cause. For BPPV, canalith repositioning maneuvers have proven effective. Vestibular suppressants can provide symptomatic relief but are not recommended for long-term use due to potential side effects. In refractory cases, vestibular rehabilitation therapy or surgical interventions may be considered.
While not routinely indicated, imaging studies like MRI or CT scan can be useful in cases where a central cause is suspected. Early identification of potentially serious conditions such as stroke or tumor is critical for guiding management.
In conclusion, vertigo requires a comprehensive clinical approach for accurate diagnosis and management. An understanding of the pathophysiology, thorough clinical assessment, appropriate use of imaging, and tailored management strategies are key to unraveling this complex symptom and improving patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation